EGFR and small cell lung carcinoma: To test this hypothesis, we analyzed by WB protein extracts from both SCLC cell lines, NCI-H82 and NCI-H196, that were treated with the EGFR-TKI Erlotinib 60 after siCtrl or siITGB2 transfection (Figure S11A).